Last 12 months
Inside the activity.
0 purchase rows · 15 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2021 Filed Feb 26, 2021 22:15 UTC |
SARAN ATULEVP, Corp Dev, GC & Secretary
|
Tax withholdingCommon Stock | 887 | $93.49 | $82,925.63 |
DisclosureSEC source: 0001367644-21-000043 · wf-form4_161437768971580.xml · nonDerivative · entry 3 SARAN ATUL · CIK 0001591070 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,323 F3 · security: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:15 UTC |
SARAN ATULEVP, Corp Dev, GC & Secretary
|
GrantCommon Stock | 3,744 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000043 · wf-form4_161437768971580.xml · nonDerivative · entry 2 SARAN ATUL · CIK 0001591070 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,210 F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA margin calculated on a cumulative basis over the three-year period beginning January 1, 2021 and ending December 31, 2023, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:15 UTC |
SARAN ATULEVP, Corp Dev, GC & Secretary
|
GrantCommon Stock | 3,744 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000043 · wf-form4_161437768971580.xml · nonDerivative · entry 1 SARAN ATUL · CIK 0001591070 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,466 F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:15 UTC |
Smith Karen L.EVP, Chief Medical Officer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 11,765 | $93.49 Strike: $93.49 | $1,099,909.85 |
DisclosureSEC source: 0001367644-21-000044 · wf-form4_161437771751742.xml · derivative · entry 3 Smith Karen L. · CIK 0001639637 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,765 Underlying: Common Stock · 11,765 shares Expires 2028-02-23 F3 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:15 UTC |
Smith Karen L.EVP, Chief Medical Officer
|
GrantCommon Stock | 2,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000044 · wf-form4_161437771751742.xml · nonDerivative · entry 2 Smith Karen L. · CIK 0001639637 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,193 F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA margin calculated on a cumulative basis over the three-year period beginning January 1, 2021 and ending December 31, 2023, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:15 UTC |
Smith Karen L.EVP, Chief Medical Officer
|
GrantCommon Stock | 2,942 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000044 · wf-form4_161437771751742.xml · nonDerivative · entry 1 Smith Karen L. · CIK 0001639637 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,252 F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 21:22 UTC |
Strei KatherineEVP, Chief HR Officer
|
Tax withholdingCommon Stock | 2,042 | $123.45 | $252,084.90 |
DisclosureSEC source: 0001367644-21-000015 · wf-form4_161309656087627.xml · nonDerivative · entry 2 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,981 F2 · security: Represents shares of common stock withheld to pay taxes due upon vesting of the PSUs. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 21:22 UTC |
Strei KatherineEVP, Chief HR Officer
|
GrantCommon Stock | 2,014 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000015 · wf-form4_161309656087627.xml · nonDerivative · entry 1 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,023 F1 · security: Consists of Performance Stock Units ("PSUs") previously granted on February 27, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year, as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 6,043 shares of common stock, which is in excess of the 4,029 shares previously reported on March 1, 2018. F1 · shares: Consists of Performance Stock Units ("PSUs") previously granted on February 27, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year, as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 6,043 shares of common stock, which is in excess of the 4,029 shares previously reported on March 1, 2018. Read SEC document |
| February 09, 2021 Filed Feb 12, 2021 02:20 UTC |
LINDAHL RICHARD SEVP, Chief Financial Officer
|
Tax withholdingCommon Stock | 2,522 | $123.45 | $311,340.90 |
DisclosureSEC source: 0001367644-21-000010 · wf-form4_161309639586111.xml · nonDerivative · entry 2 LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,779 F2 · security: Represents shares of common stock withheld to pay taxes due upon vesting of the PSUs. Read SEC document |
| February 09, 2021 Filed Feb 12, 2021 02:20 UTC |
LINDAHL RICHARD SEVP, Chief Financial Officer
|
GrantCommon Stock | 2,495 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000010 · wf-form4_161309639586111.xml · nonDerivative · entry 1 LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,301 F1 · security: Consists of Performance Stock Units ("PSUs") previously granted on May 8, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year, as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 7,486 shares of common stock, which is in excess of the 4,991 shares previously reported on May 10, 2018. F1 · shares: Consists of Performance Stock Units ("PSUs") previously granted on May 8, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year, as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 7,486 shares of common stock, which is in excess of the 4,991 shares previously reported on May 10, 2018. Read SEC document |
| February 09, 2021 Filed Feb 12, 2021 02:24 UTC |
Havey AdamEVP, Business Operations
|
Tax withholdingCommon Stock | 2,183 | $123.45 | $269,491.35 |
DisclosureSEC source: 0001367644-21-000018 · wf-form4_161309662486709.xml · nonDerivative · entry 2 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,020 F3 · security: Represents shares of common stock withheld to pay taxes due upon vesting of the PSUs. F2 · balance_after: The number of derivative securities beneficially owned was adjusted to account for a change in previously reported PSUs. 4,285 PSUs were previously reported, of which only 2,714 vested on February 11, 2020. Read SEC document |
| February 09, 2021 Filed Feb 12, 2021 02:24 UTC |
Havey AdamEVP, Business Operations
|
GrantCommon Stock | 2,518 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000018 · wf-form4_161309662486709.xml · nonDerivative · entry 1 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,203 F1 · security: Consists of Performance Stock Units ("PSUs") previously granted on February 27, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year, as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 7,554 shares of common stock, which is in excess of the 5,036 shares previously reported on March 1, 2018. F1 · shares: Consists of Performance Stock Units ("PSUs") previously granted on February 27, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year, as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 7,554 shares of common stock, which is in excess of the 5,036 shares previously reported on March 1, 2018. F2 · balance_after: The number of derivative securities beneficially owned was adjusted to account for a change in previously reported PSUs. 4,285 PSUs were previously reported, of which only 2,714 vested on February 11, 2020. Read SEC document |
| February 09, 2021 Filed Feb 12, 2021 02:23 UTC |
SARAN ATULEVP, Corp Dev, GC & Secretary
|
Tax withholdingCommon Stock | 2,430 | $123.45 | $299,983.50 |
DisclosureSEC source: 0001367644-21-000017 · wf-form4_161309660318734.xml · nonDerivative · entry 2 SARAN ATUL · CIK 0001591070 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,722 F2 · security: Represents shares of common stock withheld to pay taxes due upon vesting of the PSUs. Read SEC document |
| February 09, 2021 Filed Feb 12, 2021 02:23 UTC |
SARAN ATULEVP, Corp Dev, GC & Secretary
|
GrantCommon Stock | 2,656 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000017 · wf-form4_161309660318734.xml · nonDerivative · entry 1 SARAN ATUL · CIK 0001591070 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,152 F1 · security: Consists of Performance Stock Units ("PSUs") previously granted on February 27, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year, as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 7,969 shares of common stock, which is in excess of the 5,313 shares previously reported on March 1, 2018. F1 · shares: Consists of Performance Stock Units ("PSUs") previously granted on February 27, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year, as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 7,969 shares of common stock, which is in excess of the 5,313 shares previously reported on March 1, 2018. Read SEC document |
| February 09, 2021 Filed Feb 12, 2021 02:23 UTC |
Kramer RobertDirector · President and CEO
|
Tax withholdingCommon Stock | 423 | $123.45 | $52,219.35 |
DisclosureSEC source: 0001367644-21-000016 · wf-form4_161309658433305.xml · nonDerivative · entry 4 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,198 F2 · security: Represents shares of common stock withheld to pay taxes due upon vesting of the PSUs. Read SEC document |
| February 09, 2021 Filed Feb 12, 2021 02:23 UTC |
Kramer RobertDirector · President and CEO
|
GrantCommon Stock | 323 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000016 · wf-form4_161309658433305.xml · nonDerivative · entry 3 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,621 F3 · security: Consists of PSUs previously granted on May 8, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year,as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 969 shares of common stock, which is in excess of the 646 shares previously reported on May 10, 2018. F3 · shares: Consists of PSUs previously granted on May 8, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year,as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 969 shares of common stock, which is in excess of the 646 shares previously reported on May 10, 2018. Read SEC document |
| February 09, 2021 Filed Feb 12, 2021 02:23 UTC |
Kramer RobertDirector · President and CEO
|
Tax withholdingCommon Stock | 3,870 | $123.45 | $477,751.50 |
DisclosureSEC source: 0001367644-21-000016 · wf-form4_161309658433305.xml · nonDerivative · entry 2 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,298 F2 · security: Represents shares of common stock withheld to pay taxes due upon vesting of the PSUs. Read SEC document |
| February 09, 2021 Filed Feb 12, 2021 02:23 UTC |
Kramer RobertDirector · President and CEO
|
GrantCommon Stock | 2,958 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000016 · wf-form4_161309658433305.xml · nonDerivative · entry 1 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,168 F1 · security: Consists of Performance Stock Units ("PSUs") previously granted on February 27, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year, as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 8,875 shares of common stock, which is in excess of the 5,917 shares previously reported on March 1, 2018. F1 · shares: Consists of Performance Stock Units ("PSUs") previously granted on February 27, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year, as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 8,875 shares of common stock, which is in excess of the 5,917 shares previously reported on March 1, 2018. Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 22:23 UTC |
Kramer RobertDirector · President and CEO
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 13,000 | $120.03 Strike: $30.63 | $1,560,390.00 |
DisclosureSEC source: 0001367644-21-000008 · wf-form4_161290942063298.xml · derivative · entry 6 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,638 Underlying: Common Stock · 13,000 shares Expires 2024-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Consists of an option granted on 2/28/2017 under the company's stock incentive plan as amended and restated. F2 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F5 · price: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.19. F6 · derivative.exercise_date: The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant. Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 22:23 UTC |
Kramer RobertDirector · President and CEO
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 32,397 | $120.03 Strike: $30.86 | $3,888,611.91 |
DisclosureSEC source: 0001367644-21-000008 · wf-form4_161290942063298.xml · derivative · entry 5 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 32,397 shares Expires 2023-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Consists of an option granted on 3/1/2016 under the company's stock incentive plan as amended and restated. F2 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F3 · price: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.20. F6 · derivative.exercise_date: The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant. Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 22:23 UTC |
Kramer RobertDirector · President and CEO
|
SaleCommon Stock | 13,000 | $120.03 | $1,560,390.00 |
DisclosureSEC source: 0001367644-21-000008 · wf-form4_161290942063298.xml · nonDerivative · entry 4 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,210 F4 · security: Consists of an option granted on 2/28/2017 under the company's stock incentive plan as amended and restated. F2 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F5 · price: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.19. Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 22:23 UTC |
Kramer RobertDirector · President and CEO
|
Exercise / conversionCommon Stock | 13,000 | $30.63 | $398,190.00 |
DisclosureSEC source: 0001367644-21-000008 · wf-form4_161290942063298.xml · nonDerivative · entry 3 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,210 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Consists of an option granted on 2/28/2017 under the company's stock incentive plan as amended and restated. F2 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 22:23 UTC |
Kramer RobertDirector · President and CEO
|
SaleCommon Stock | 32,397 | $120.03 | $3,888,611.91 |
DisclosureSEC source: 0001367644-21-000008 · wf-form4_161290942063298.xml · nonDerivative · entry 2 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,210 F1 · security: Consists of an option granted on 3/1/2016 under the company's stock incentive plan as amended and restated. F2 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F3 · price: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.20. Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 22:23 UTC |
Kramer RobertDirector · President and CEO
|
Exercise / conversionCommon Stock | 32,397 | $30.86 | $999,771.42 |
DisclosureSEC source: 0001367644-21-000008 · wf-form4_161290942063298.xml · nonDerivative · entry 1 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Consists of an option granted on 3/1/2016 under the company's stock incentive plan as amended and restated. F2 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Read SEC document |
| January 21, 2021 Filed Jan 22, 2021 21:14 UTC |
Kramer RobertDirector · President and CEO
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 21,900 | $110.03 Strike: $26.45 | $2,409,657.00 |
DisclosureSEC source: 0001367644-21-000006 · wf-form4_161135005224162.xml · derivative · entry 6 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,900 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Consists of an option granted on 03/10/2015 under the company's stock incentive plan as amended and restated. F2 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F3 · price: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $110.00 to $110.36. F4 · derivative.exercise_date: The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant. Read SEC document |
| January 21, 2021 Filed Jan 22, 2021 21:14 UTC |
Kramer RobertDirector · President and CEO
|
SaleCommon Stock | 21,900 | $110.03 | $2,409,657.00 |
DisclosureSEC source: 0001367644-21-000006 · wf-form4_161135005224162.xml · nonDerivative · entry 4 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,210 F1 · security: Consists of an option granted on 03/10/2015 under the company's stock incentive plan as amended and restated. F2 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F3 · price: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $110.00 to $110.36. Read SEC document |
| January 21, 2021 Filed Jan 22, 2021 21:14 UTC |
Kramer RobertDirector · President and CEO
|
Exercise / conversionCommon Stock | 21,900 | $26.45 | $579,255.00 |
DisclosureSEC source: 0001367644-21-000006 · wf-form4_161135005224162.xml · nonDerivative · entry 3 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,110 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Consists of an option granted on 03/10/2015 under the company's stock incentive plan as amended and restated. F2 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 21:14 UTC |
Kramer RobertDirector · President and CEO
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 2,232 | $110.00 Strike: $26.45 | $245,520.00 |
DisclosureSEC source: 0001367644-21-000006 · wf-form4_161135005224162.xml · derivative · entry 5 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,900 Underlying: Common Stock · 2,232 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Consists of an option granted on 03/10/2015 under the company's stock incentive plan as amended and restated. F2 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F4 · derivative.exercise_date: The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 21:14 UTC |
Kramer RobertDirector · President and CEO
|
SaleCommon Stock | 2,232 | $110.00 | $245,520.00 |
DisclosureSEC source: 0001367644-21-000006 · wf-form4_161135005224162.xml · nonDerivative · entry 2 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,210 F1 · security: Consists of an option granted on 03/10/2015 under the company's stock incentive plan as amended and restated. F2 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 21:14 UTC |
Kramer RobertDirector · President and CEO
|
Exercise / conversionCommon Stock | 2,232 | $26.45 | $59,036.40 |
DisclosureSEC source: 0001367644-21-000006 · wf-form4_161135005224162.xml · nonDerivative · entry 1 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,442 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Consists of an option granted on 03/10/2015 under the company's stock incentive plan as amended and restated. F2 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Read SEC document |
| January 15, 2021 Filed Jan 19, 2021 21:28 UTC |
Kramer RobertDirector · President and CEO
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 19,026 | $0.00 Strike: $25.62 | $0.00 |
DisclosureSEC source: 0001367644-21-000004 · wf-form4_161109171024831.xml · derivative · entry 3 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,026 shares Expires 2021-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F1 · derivative.exercise_date: Consists of an option granted on 03/11/2014 under the company's stock incentive plan as amended and restated. Read SEC document |
| January 15, 2021 Filed Jan 19, 2021 21:28 UTC |
Kramer RobertDirector · President and CEO
|
SaleCommon Stock | 19,026 | $106.01 | $2,016,900.60 |
DisclosureSEC source: 0001367644-21-000004 · wf-form4_161109171024831.xml · nonDerivative · entry 2 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,210 F1 · security: Consists of an option granted on 03/11/2014 under the company's stock incentive plan as amended and restated. F2 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F4 · price: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $104.52 to $107.79. F3 · balance_after: The number of derivative securities beneficially owned was adjusted to account for a change in previously reported PSUs. 8,163 PSUs were previously reported, of which only 5,169 vested on February 11, 2020. Read SEC document |
| January 15, 2021 Filed Jan 19, 2021 21:28 UTC |
Kramer RobertDirector · President and CEO
|
Exercise / conversionCommon Stock | 19,026 | $25.62 | $487,446.12 |
DisclosureSEC source: 0001367644-21-000004 · wf-form4_161109171024831.xml · nonDerivative · entry 1 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,236 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Consists of an option granted on 03/11/2014 under the company's stock incentive plan as amended and restated. F2 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F3 · balance_after: The number of derivative securities beneficially owned was adjusted to account for a change in previously reported PSUs. 8,163 PSUs were previously reported, of which only 5,169 vested on February 11, 2020. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 23:30 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 19,391 | $0.00 Strike: $26.45 | $0.00 |
DisclosureSEC source: 0000899243-20-030866 · doc4.xml · derivative · entry 8 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,391 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on February 25, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F6 · derivative.exercise_date: The options vested in three equal installments on March 9 2016, March 9, 2017 and March 9, 2018. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 23:30 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
SaleCommon Stock | 19,391 | $88.21 | $1,710,480.11 |
DisclosureSEC source: 0000899243-20-030866 · doc4.xml · nonDerivative · entry 4 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,123,988 F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on February 25, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F3 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.69 to $90.00. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 23:30 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionCommon Stock | 19,391 | $26.45 | $512,891.95 |
DisclosureSEC source: 0000899243-20-030866 · doc4.xml · nonDerivative · entry 3 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,143,379 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on February 25, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 23:30 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $26.45 | $0.00 |
DisclosureSEC source: 0000899243-20-030866 · doc4.xml · derivative · entry 7 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,391 Underlying: Common Stock · 20,000 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on February 25, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F6 · derivative.exercise_date: The options vested in three equal installments on March 9 2016, March 9, 2017 and March 9, 2018. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 23:30 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
SaleCommon Stock | 20,000 | $95.26 | $1,905,200.00 |
DisclosureSEC source: 0000899243-20-030866 · doc4.xml · nonDerivative · entry 2 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,123,988 F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on February 25, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F2 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.85 to $98.49. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 23:30 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionCommon Stock | 20,000 | $26.45 | $529,000.00 |
DisclosureSEC source: 0000899243-20-030866 · doc4.xml · nonDerivative · entry 1 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,143,988 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on February 25, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 01:53 UTC |
El-Hibri FuadDirector · Chairman
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $26.45 | $0.00 |
DisclosureSEC source: 0000899243-20-030431 · doc4.xml · derivative · entry 8 El-Hibri Fuad · CIK 0001380185 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,391 Underlying: Common Stock · 20,000 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on February 25, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F6 · derivative.exercise_date: The options vested in three equal installments on March 9, 2016, March 9, 2017 and March 9, 2018. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 01:53 UTC |
El-Hibri FuadDirector · Chairman
|
SaleCommon Stock | 20,000 | $90.74 | $1,814,800.00 |
DisclosureSEC source: 0000899243-20-030431 · doc4.xml · nonDerivative · entry 4 El-Hibri Fuad · CIK 0001380185 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,123,988 F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on February 25, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F3 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.97 to $92.24. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 01:53 UTC |
El-Hibri FuadDirector · Chairman
|
Exercise / conversionCommon Stock | 20,000 | $26.45 | $529,000.00 |
DisclosureSEC source: 0000899243-20-030431 · doc4.xml · nonDerivative · entry 3 El-Hibri Fuad · CIK 0001380185 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,143,988 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on February 25, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Read SEC document |
| November 02, 2020 Filed Nov 5, 2020 01:53 UTC |
El-Hibri FuadDirector · Chairman
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $26.45 | $0.00 |
DisclosureSEC source: 0000899243-20-030431 · doc4.xml · derivative · entry 7 El-Hibri Fuad · CIK 0001380185 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,391 Underlying: Common Stock · 20,000 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on February 25, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F6 · derivative.exercise_date: The options vested in three equal installments on March 9, 2016, March 9, 2017 and March 9, 2018. Read SEC document |
| November 02, 2020 Filed Nov 5, 2020 01:53 UTC |
El-Hibri FuadDirector · Chairman
|
SaleCommon Stock | 20,000 | $90.44 | $1,808,800.00 |
DisclosureSEC source: 0000899243-20-030431 · doc4.xml · nonDerivative · entry 2 El-Hibri Fuad · CIK 0001380185 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,123,988 F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on February 25, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F2 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.40 to $91.62. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| November 02, 2020 Filed Nov 5, 2020 01:53 UTC |
El-Hibri FuadDirector · Chairman
|
Exercise / conversionCommon Stock | 20,000 | $26.45 | $529,000.00 |
DisclosureSEC source: 0000899243-20-030431 · doc4.xml · nonDerivative · entry 1 El-Hibri Fuad · CIK 0001380185 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,143,988 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on February 25, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 21:28 UTC |
White Marvin LDirector
|
GrantCommon Stock | 3,629 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-20-000151 · wf-form4_160193327342258.xml · nonDerivative · entry 1 White Marvin L · CIK 0001493324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,629 F1 · security: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated. F2 · shares: These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service on the Board of Directors. Read SEC document |
| September 24, 2020 Filed Sep 25, 2020 23:00 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
SaleCommon Stock | 12,535 | $98.85 | $1,239,084.75 |
DisclosureSEC source: 0000899243-20-026348 · doc4.xml · nonDerivative · entry 2 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,123,988 F1 · kind: The transaction was made by the Reporting Person pursuant to a trading plan adopted by Fuad El-Hibri Nancy El-Hibri JTWROS on February 25, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934 (the "Exchange Act"). F3 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.84 to $100.44. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| September 23, 2020 Filed Sep 25, 2020 23:00 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
SaleCommon Stock | 13,000 | $100.58 | $1,307,540.00 |
DisclosureSEC source: 0000899243-20-026348 · doc4.xml · nonDerivative · entry 1 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,136,523 F1 · kind: The transaction was made by the Reporting Person pursuant to a trading plan adopted by Fuad El-Hibri Nancy El-Hibri JTWROS on February 25, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934 (the "Exchange Act"). F2 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.86 to $102.63. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| September 17, 2020 Filed Sep 18, 2020 22:25 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
SaleCommon Stock | 20,000 | $100.68 | $2,013,600.00 |
DisclosureSEC source: 0000899243-20-025750 · doc4.xml · nonDerivative · entry 2 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,149,523 F1 · kind: The transaction was made by the Reporting Person pursuant to a trading plan adopted by Fuad El-Hibri Nancy El-Hibri JTWROS on February 25, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934. F3 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.07 to $102.18. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| September 16, 2020 Filed Sep 18, 2020 20:24 UTC |
SULLIVAN LOUIS WDirector
|
GiftCommon Stock | 10,004 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-20-000147 · wf-form4_160046066724906.xml · nonDerivative · entry 1 SULLIVAN LOUIS W · CIK 0001193522 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,758 F1 · security: This transaction represents a gift / charitable donation to the Sullivan Family Foundation. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.